Baxter International (NYSE:BAX) Share Price Crosses Below 50 Day Moving Average – Time to Sell?

Baxter International Inc. (NYSE:BAX) crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $24.65 and traded as low as $23.37. Baxter International shares last traded at $23.4770, with a volume of 15,668,814 shares changing hands.

Key Stories Impacting Baxter International

Here are the key news stories impacting Baxter International this week:

• Positive Sentiment: Baxter reported third-quarter adjusted earnings of $0.58 per share, above analysts’ estimates of approximately $0.51–$0.52, while revenue reached $2.98 billion versus the $2.91 billion consensus. Sales increased 5% from the prior year. Baxter International Q3 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management raised its full-year 2026 earnings outlook, citing broad-based segment growth despite ongoing margin pressure. The improved guidance is a positive signal for future earnings and cash generation. Baxter Q3 Earnings Beat on Broad-Based Growth, 2026 Outlook Raised
• Positive Sentiment: Baxter declared its quarterly dividend alongside the results, maintaining shareholder returns while reporting a profitable quarter. Baxter Raises 2026 Guidance and Declares Quarterly Dividend
• Neutral Sentiment: The earnings call and financial schedules provide additional detail on segment performance, the updated outlook and the company’s plans to address margin pressure. Baxter Q3 2026 Earnings Call Transcript
• Negative Sentiment: Although earnings exceeded expectations, quarterly EPS fell from $0.69 a year earlier to $0.58. Continued margin pressure and Baxter’s negative net margin remain concerns for investors. Baxter Reports Third-Quarter Results

Analyst Ratings Changes

Several equities research analysts recently commented on BAX shares. Zacks Research upgraded Baxter International from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Wells Fargo & Company upped their price target on Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. UBS Group increased their price target on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. TD Cowen raised their target price on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Finally, Barclays assumed coverage on shares of Baxter International in a research report on Wednesday, October 7th. They set an “underweight” rating and a $20.00 target price for the company. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $22.27.

Baxter International Stock Performance

The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The firm has a market capitalization of $12.14 billion, a price-to-earnings ratio of -11.34, a price-to-earnings-growth ratio of 3.85 and a beta of 0.65. The stock’s fifty day moving average is $24.65 and its two-hundred day moving average is $21.35.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The business had revenue of $2.98 billion during the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The business’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.69 earnings per share. Analysts forecast that Baxter International Inc. will post 2.04 earnings per share for the current year.

Hedge Funds Weigh In On Baxter International

Hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. bought a new stake in shares of Baxter International during the 2nd quarter worth about $1,744,874,000. Pzena Investment Management LLC bought a new stake in Baxter International during the second quarter worth approximately $1,392,098,000. Equity Investment Corp acquired a new stake in Baxter International in the second quarter worth approximately $146,815,000. Bank of America Corp DE bought a new position in Baxter International during the 2nd quarter valued at $132,993,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Baxter International during the 2nd quarter valued at $68,036,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.